Stefan P Kastl Selected Research

Stefan P Kastl Research Topics

Disease

5	Coronary Artery Disease (Coronary Atherosclerosis) 05/2021 - 12/2014
5	Myocardial Infarction 01/2017 - 11/2005
4	Atherosclerosis 07/2015 - 11/2005
4	Inflammation (Inflammations) 03/2011 - 02/2007
3	Heart Failure 01/2019 - 02/2015
2	Heart Arrest (Cardiac Arrest) 01/2021 - 10/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 03/2011
2	Atherosclerotic Plaque (Atheroma) 09/2011 - 03/2004
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2020
1	Critical Illness (Critically Ill) 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Cardiogenic Shock 01/2019
1	Necrosis 02/2015
1	Neointima 06/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2012
1	Pathologic Neovascularization 03/2011
1	Rupture 01/2011
1	Vascular Diseases (Vascular Disease) 09/2009
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2009
1	Pre-Eclampsia (Preeclampsia) 01/2009
1	Wounds and Injuries (Trauma) 01/2008
1	Acute-Phase Reaction 01/2008
1	Thrombosis (Thrombus) 01/2008
1	Stable Angina 01/2008
1	Intermittent Claudication 02/2007
1	Hypoxia (Hypoxemia) 06/2006
1	Stroke (Strokes) 11/2005

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 03/2011 - 06/2006
3	Oncostatin MIBA 03/2011 - 03/2008
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2011
2	Simendan (Levosimendan)IBA 01/2017 - 02/2015
2	omega-Chloroacetophenone (Mace)IBA 01/2015 - 11/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014 - 03/2011
2	Matrix Metalloproteinases (MMPs)IBA 01/2011 - 03/2004
2	C-Reactive ProteinIBA 02/2007 - 11/2005
1	Proprotein Convertase 9IBA 05/2021
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2021
1	Toll-Like Receptor 2IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020
1	SerpinsIBA 01/2020
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Fatty Acid-Binding ProteinsIBA 01/2019
1	Lipoprotein(a)IBA 07/2015
1	Chemotactic FactorsIBA 02/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2015
1	oxidized low density lipoproteinIBA 01/2015
1	Lipoproteins (Lipoprotein)IBA 01/2015
1	HDL LipoproteinsIBA 12/2014
1	Triglycerides (Triacylglycerol)IBA 05/2012
1	Glucose (Dextrose)FDA LinkGeneric 05/2012
1	HDL CholesterolIBA 05/2012
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2011
1	Messenger RNA (mRNA)IBA 09/2011
1	Interleukin-33IBA 09/2011
1	SelectinsIBA 09/2011
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2011
1	LigandsIBA 03/2011
1	Glycoproteins (Glycoprotein)IBA 03/2011
1	2- phenyl- 5,5- dimethyltetrahydro- 1,4- oxazineIBA 03/2011
1	Thrombin FDA Link 09/2009
1	EnzymesIBA 09/2009
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2009
1	pro-brain natriuretic peptide (1-76)IBA 01/2009
1	Plasminogen Activator Inhibitor 1IBA 01/2008
1	Clopidogrel (Plavix)FDA Link 01/2008
1	AntigensIBA 02/2007
1	ChemokinesIBA 06/2006
1	Monocyte Chemoattractant ProteinsIBA 06/2006
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 11/2005
1	Fibrinogen (Factor I)FDA Link 11/2005
1	Complement System Proteins (Complement)IBA 11/2005

Therapy/Procedure

2	Percutaneous Coronary Intervention 01/2020 - 11/2005
2	Stents 01/2015 - 01/2008
1	Drug-Eluting Stents 01/2020
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2005